Laurus Labs share price at record high after Q2 results 2026, dividend announcement
60-Word AI Digest
Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.
Key Takeaways
- Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%.
- The company declared an interim dividend and expanded peptide manufacturing.
- While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.
Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.
Original Publisher Attribution
This summary was curated from Should you buy pharma stock?.